These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 15757469)

  • 1. The economics of vaccination from a global perspective: present and future. 2-3 December, 2004, Vaccines: all things considered, San Francisco, CA, USA.
    Ehreth J
    Expert Rev Vaccines; 2005 Feb; 4(1):19-21. PubMed ID: 15757469
    [No Abstract]   [Full Text] [Related]  

  • 2. Medicine. The intangible value of vaccination.
    Rappuoli R; Miller HI; Falkow S
    Science; 2002 Aug; 297(5583):937-9. PubMed ID: 12169712
    [No Abstract]   [Full Text] [Related]  

  • 3. Vaccines-all things considered. Part II. 2-3 December 2004, San Francisco, CA, USA.
    Rosenthal KS
    IDrugs; 2005 Feb; 8(2):110-1. PubMed ID: 15696409
    [No Abstract]   [Full Text] [Related]  

  • 4. [Reasons for an injury compensation programme for adverse vaccine-related events in Spain].
    Tuells J
    Med Clin (Barc); 2013 Jun; 140(12):554-7. PubMed ID: 23540383
    [No Abstract]   [Full Text] [Related]  

  • 5. Vaccine candidates for poor nations are going to waste.
    Kaslow DC; Black S; Bloom DE; Datla M; Salisbury D; Rappuoli R
    Nature; 2018 Dec; 564(7736):337-339. PubMed ID: 30560957
    [No Abstract]   [Full Text] [Related]  

  • 6. Questions raised about whether compulsory licenses get best prices.
    Owens B
    Nat Med; 2015 Apr; 21(4):300. PubMed ID: 25849264
    [No Abstract]   [Full Text] [Related]  

  • 7. Patents: a threat to innovation?
    Manocaran M
    Science; 2010 Jan; 327(5961):31-2; author reply 32. PubMed ID: 20044557
    [No Abstract]   [Full Text] [Related]  

  • 8. Veterinary vaccines in an economic and sociopolitical context. The viewpoint of the veterinary pharmaceutical industry.
    Gug M
    Dev Biol Stand; 1992; 79():31-6. PubMed ID: 1286762
    [No Abstract]   [Full Text] [Related]  

  • 9. The HEALTH Act's FDA defense to punitive damages: a gift to drug makers or to the public?
    Levy E
    Fordham Law Rev; 2006 Mar; 74(4):2425-60. PubMed ID: 17115481
    [No Abstract]   [Full Text] [Related]  

  • 10. Biotech patents-business as usual?
    Lawrence S
    Nat Biotechnol; 2008 Dec; 26(12):1326. PubMed ID: 19060861
    [No Abstract]   [Full Text] [Related]  

  • 11. Canada to change patent law to allow export of cheap drugs.
    Kondro W
    Lancet; 2003 Oct; 362(9392):1290. PubMed ID: 14577437
    [No Abstract]   [Full Text] [Related]  

  • 12. A generic problem.
    Hanauer SB
    Nat Clin Pract Gastroenterol Hepatol; 2006 Dec; 3(12):649. PubMed ID: 17130869
    [No Abstract]   [Full Text] [Related]  

  • 13. A precarious balancing act--the role of the FDA as protector of public health and industry wealth.
    McCabe AR
    Suffolk Univ Law Rev; 2003; 36(3):787-819. PubMed ID: 16493844
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmaceutical patent settlements: the antitrust risks.
    Balto DA
    Food Drug Law J; 2000; 55(3):321-41. PubMed ID: 11824464
    [No Abstract]   [Full Text] [Related]  

  • 15. US policy may encourage counterfeit drugs.
    Bouchie A
    Nat Biotechnol; 2003 Feb; 21(2):121. PubMed ID: 12560826
    [No Abstract]   [Full Text] [Related]  

  • 16. Key drivers behind the development of global vaccine market.
    Gréco M
    Vaccine; 2001 Feb; 19(13-14):1606-10. PubMed ID: 11166882
    [No Abstract]   [Full Text] [Related]  

  • 17. Vaccines--all things considered. Part I. 2-3 December 2004, San Francisco, CA, USA.
    Rosenthal KS
    IDrugs; 2005 Feb; 8(2):107-9. PubMed ID: 15696408
    [No Abstract]   [Full Text] [Related]  

  • 18. Delaying generic competition--corporate payoffs and the future of Plavix.
    Shuchman M
    N Engl J Med; 2006 Sep; 355(13):1297-300. PubMed ID: 17005945
    [No Abstract]   [Full Text] [Related]  

  • 19. Intellectual property. Balancing innovation and access: patent challenges tip the scales.
    Higgins MJ; Graham SJ
    Science; 2009 Oct; 326(5951):370-1. PubMed ID: 19833944
    [No Abstract]   [Full Text] [Related]  

  • 20. India remains on US trade "priority watch list" for failing to uphold international drug company patents.
    Arie S
    BMJ; 2013 May; 346():f2949. PubMed ID: 23657189
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.